ARCHIVES

Collaborative Drug Development Groups Clear BSC Overview, Natural Products RFA To Proceed

This article is from The Cancer Letter archive.

Vol. 14 No. 24 | June 10, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Approves Votrient For Soft Tissue Sarcomas

April 27, 2012

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981

South African Investigator Bezwoda Admits Falsifying Data In High-Dose Chemo Study.

February 11, 2000

MIT Radiation Poisoning Was Deliberate, NRC Investigation Finds

December 15, 1995

Abstracts of ‘Most Newsworthy’ Papers

June 3, 1977